| NOVO-NORDISK B ADR/1DK 10 |
| USA |
| Gesundheit |
| US6701002056 / 866931 |
| NOVA (Frankfurt) / NVO (NYSE) |
| FRA:NOVA, ETR:NOVA, NOVA:GR, NYSE:NVO |
| - |
| https://www.novonordisk.c.. |
|
Novo Nordisk A/S Sponsored ADR represents Novo Nordisk A/S, a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark. The company focuses on researching, developing, manufactu..
>Volltext.. |
| 142007.83 Mio. EUR |
| 156111.53 Mio. EUR |
| 40334.27 Mio. EUR |
| 19501.21 Mio. EUR |
| 13321.39 Mio. EUR |
| 3 EUR |
| 17760.22 Mio. EUR |
| 3588.99 Mio. EUR |
| 15592.65 Mio. EUR |
| 0.13 |
| 11.11% |
| 5.44% |
| 1.48 EUR |
| 3.26% |
| 3.26% |
| 18.08.25 - 0.5013465€ 31.03.25 - 0.9803173€ >weitere anzeigen... |
| - |
| NOVO NORDISK ADR, NOVO NORDISK, NOVONORDISK |
| 04.03.26 |
|